The relationship between treatment time of gemcitabine and development of hematologic toxicity in cancer patients. [electronic resource]
- Biological & pharmaceutical bulletin 2011
- 1765-8 p. digital
Publication Type: Journal Article
1347-5215
10.1248/bpb.34.1765 doi
Adult Aged Aged, 80 and over Antineoplastic Agents--administration & dosage Circadian Rhythm Deoxycytidine--administration & dosage Drug Administration Schedule Female Humans Leukocyte Count Male Middle Aged Neoplasms--drug therapy Odds Ratio Retrospective Studies Gemcitabine